PDB Short entry for 2Q7R HEADER MEMBRANE PROTEIN, LIPID TRANSPORT 07-JUN-07 2Q7R TITLE CRYSTAL STRUCTURE OF HUMAN FLAP WITH AN IODINATED ANALOG OF MK-591 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: FLAP, MK-886-BINDING PROTEIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALOX5AP, FLAP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS FLAP, MAPEG, MEMBRANE PROTEIN, LIPID TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR A.D.FERGUSON REVDAT 3 20-OCT-21 2Q7R 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2Q7R 1 VERSN REVDAT 1 21-AUG-07 2Q7R 0 JRNL AUTH A.D.FERGUSON,B.M.MCKEEVER,S.XU,D.WISNIEWSKI,D.K.MILLER, JRNL AUTH 2 T.T.YAMIN,R.H.SPENCER,L.CHU,F.UJJAINWALLA,B.R.CUNNINGHAM, JRNL AUTH 3 J.F.EVANS,J.W.BECKER JRNL TITL CRYSTAL STRUCTURE OF INHIBITOR-BOUND HUMAN JRNL TITL 2 5-LIPOXYGENASE-ACTIVATING PROTEIN. JRNL REF SCIENCE V. 317 510 2007 JRNL REFN ISSN 0036-8075 JRNL PMID 17600184 JRNL DOI 10.1126/SCIENCE.1144346 REMARK 2 REMARK 2 RESOLUTION. 4.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 1.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 19874 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.268 REMARK 3 R VALUE (WORKING SET) : 0.268 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 1011 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 4.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 4.24 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.54 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3136 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3108 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2993 REMARK 3 BIN R VALUE (WORKING SET) : 0.3105 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.56 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6996 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 258 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 98.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 120.7 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.39651 REMARK 3 B22 (A**2) : -3.39651 REMARK 3 B33 (A**2) : 6.79302 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7460 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 10134 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 1302 ; 0.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 216 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 1092 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 7460 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 589 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.72 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q7R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000043255. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9797 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20007 REMARK 200 RESOLUTION RANGE HIGH (A) : 4.000 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 15.50 REMARK 200 R MERGE (I) : 0.11100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 4.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 4.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 15.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.290 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 76.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 4000, 0.32 LICL2, 1 MM TCEP, REMARK 280 PH 5.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K, PH 5.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 90.33000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 90.33000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 90.33000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 90.33000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 90.33000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 90.33000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 90.33000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 90.33000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A TRIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8550 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8490 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 141 REMARK 465 ASP A 142 REMARK 465 PHE A 143 REMARK 465 GLU A 144 REMARK 465 ASN A 145 REMARK 465 TYR A 146 REMARK 465 ILE A 147 REMARK 465 ALA A 148 REMARK 465 THR A 149 REMARK 465 ILE A 150 REMARK 465 SER A 151 REMARK 465 THR A 152 REMARK 465 THR A 153 REMARK 465 ILE A 154 REMARK 465 SER A 155 REMARK 465 PRO A 156 REMARK 465 LEU A 157 REMARK 465 LEU A 158 REMARK 465 LEU A 159 REMARK 465 ILE A 160 REMARK 465 PRO A 161 REMARK 465 THR B 149 REMARK 465 ILE B 150 REMARK 465 SER B 151 REMARK 465 THR B 152 REMARK 465 THR B 153 REMARK 465 ILE B 154 REMARK 465 SER B 155 REMARK 465 PRO B 156 REMARK 465 LEU B 157 REMARK 465 LEU B 158 REMARK 465 LEU B 159 REMARK 465 ILE B 160 REMARK 465 PRO B 161 REMARK 465 ILE C 150 REMARK 465 SER C 151 REMARK 465 THR C 152 REMARK 465 THR C 153 REMARK 465 ILE C 154 REMARK 465 SER C 155 REMARK 465 PRO C 156 REMARK 465 LEU C 157 REMARK 465 LEU C 158 REMARK 465 LEU C 159 REMARK 465 ILE C 160 REMARK 465 PRO C 161 REMARK 465 THR D 149 REMARK 465 ILE D 150 REMARK 465 SER D 151 REMARK 465 THR D 152 REMARK 465 THR D 153 REMARK 465 ILE D 154 REMARK 465 SER D 155 REMARK 465 PRO D 156 REMARK 465 LEU D 157 REMARK 465 LEU D 158 REMARK 465 LEU D 159 REMARK 465 ILE D 160 REMARK 465 PRO D 161 REMARK 465 SER E 141 REMARK 465 ASP E 142 REMARK 465 PHE E 143 REMARK 465 GLU E 144 REMARK 465 ASN E 145 REMARK 465 TYR E 146 REMARK 465 ILE E 147 REMARK 465 ALA E 148 REMARK 465 THR E 149 REMARK 465 ILE E 150 REMARK 465 SER E 151 REMARK 465 THR E 152 REMARK 465 THR E 153 REMARK 465 ILE E 154 REMARK 465 SER E 155 REMARK 465 PRO E 156 REMARK 465 LEU E 157 REMARK 465 LEU E 158 REMARK 465 LEU E 159 REMARK 465 ILE E 160 REMARK 465 PRO E 161 REMARK 465 ILE F 150 REMARK 465 SER F 151 REMARK 465 THR F 152 REMARK 465 THR F 153 REMARK 465 ILE F 154 REMARK 465 SER F 155 REMARK 465 PRO F 156 REMARK 465 LEU F 157 REMARK 465 LEU F 158 REMARK 465 LEU F 159 REMARK 465 ILE F 160 REMARK 465 PRO F 161 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 110 C - N - CA ANGL. DEV. = 17.9 DEGREES REMARK 500 PRO A 110 C - N - CD ANGL. DEV. = -17.4 DEGREES REMARK 500 SER C 108 N - CA - C ANGL. DEV. = -18.4 DEGREES REMARK 500 THR C 109 N - CA - C ANGL. DEV. = 21.3 DEGREES REMARK 500 PRO E 110 C - N - CA ANGL. DEV. = 11.3 DEGREES REMARK 500 PRO E 110 C - N - CD ANGL. DEV. = -23.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 3 -39.08 -32.95 REMARK 500 ASN A 8 25.93 -68.90 REMARK 500 VAL A 9 -18.36 -153.08 REMARK 500 THR A 36 -74.84 -65.02 REMARK 500 THR A 45 99.29 -47.18 REMARK 500 GLN A 58 12.29 -69.62 REMARK 500 TYR A 64 -58.41 -25.56 REMARK 500 LEU A 76 -61.52 -104.89 REMARK 500 SER A 79 131.14 -37.11 REMARK 500 GLN A 80 -71.46 -22.68 REMARK 500 VAL A 81 -73.31 -42.20 REMARK 500 LEU A 102 -108.10 -93.00 REMARK 500 ALA A 128 -82.76 -68.06 REMARK 500 PHE A 139 56.80 -96.69 REMARK 500 GLN B 3 -36.06 -34.62 REMARK 500 GLU B 4 -70.76 -57.17 REMARK 500 ASN B 8 24.47 -66.11 REMARK 500 VAL B 9 -19.80 -151.79 REMARK 500 THR B 36 -11.13 -34.42 REMARK 500 GLN B 37 -127.25 -175.94 REMARK 500 ARG B 40 105.15 -45.03 REMARK 500 SER B 41 47.88 87.44 REMARK 500 PHE B 42 61.09 8.09 REMARK 500 THR B 45 14.65 168.80 REMARK 500 THR B 47 155.27 61.31 REMARK 500 LEU B 48 -134.40 54.58 REMARK 500 ALA B 49 -23.26 -33.64 REMARK 500 GLN B 58 2.06 -62.51 REMARK 500 TYR B 64 -58.24 -29.40 REMARK 500 CYS B 78 133.24 173.14 REMARK 500 SER B 79 -65.34 89.38 REMARK 500 GLN B 80 -75.57 73.78 REMARK 500 LEU B 102 -76.04 -64.76 REMARK 500 ARG B 105 -155.01 76.85 REMARK 500 THR B 106 141.47 56.13 REMARK 500 GLN B 107 88.56 -53.98 REMARK 500 THR B 109 45.09 33.70 REMARK 500 PRO B 110 -32.96 -34.93 REMARK 500 PHE B 114 -63.23 -178.17 REMARK 500 LYS B 116 -102.83 44.21 REMARK 500 ALA B 128 -82.44 -74.92 REMARK 500 PHE B 138 -66.06 -95.37 REMARK 500 SER B 141 -117.22 -90.32 REMARK 500 ASP B 142 -95.64 47.14 REMARK 500 PHE B 143 33.78 18.23 REMARK 500 ASN B 145 64.63 -101.29 REMARK 500 TYR B 146 58.93 -59.83 REMARK 500 ILE B 147 69.96 -64.65 REMARK 500 GLN C 3 -34.29 -33.70 REMARK 500 ASN C 8 25.57 -65.26 REMARK 500 REMARK 500 THIS ENTRY HAS 133 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3CS C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3CS B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3CS A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3CS F 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3CS D 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3CS E 506 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q7M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN FLAP WITH MK-591 DBREF 2Q7R A 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7R B 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7R C 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7R D 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7R E 1 161 UNP P20292 AL5AP_HUMAN 1 161 DBREF 2Q7R F 1 161 UNP P20292 AL5AP_HUMAN 1 161 SEQADV 2Q7R MSE A 1 UNP P20292 MET 1 MODIFIED RESIDUE SEQADV 2Q7R MSE A 89 UNP P20292 MET 89 MODIFIED RESIDUE SEQADV 2Q7R MSE A 125 UNP P20292 MET 125 MODIFIED RESIDUE SEQADV 2Q7R ALA A 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7R MSE B 1 UNP P20292 MET 1 MODIFIED RESIDUE SEQADV 2Q7R MSE B 89 UNP P20292 MET 89 MODIFIED RESIDUE SEQADV 2Q7R MSE B 125 UNP P20292 MET 125 MODIFIED RESIDUE SEQADV 2Q7R ALA B 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7R MSE C 1 UNP P20292 MET 1 MODIFIED RESIDUE SEQADV 2Q7R MSE C 89 UNP P20292 MET 89 MODIFIED RESIDUE SEQADV 2Q7R MSE C 125 UNP P20292 MET 125 MODIFIED RESIDUE SEQADV 2Q7R ALA C 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7R MSE D 1 UNP P20292 MET 1 MODIFIED RESIDUE SEQADV 2Q7R MSE D 89 UNP P20292 MET 89 MODIFIED RESIDUE SEQADV 2Q7R MSE D 125 UNP P20292 MET 125 MODIFIED RESIDUE SEQADV 2Q7R ALA D 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7R MSE E 1 UNP P20292 MET 1 MODIFIED RESIDUE SEQADV 2Q7R MSE E 89 UNP P20292 MET 89 MODIFIED RESIDUE SEQADV 2Q7R MSE E 125 UNP P20292 MET 125 MODIFIED RESIDUE SEQADV 2Q7R ALA E 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQADV 2Q7R MSE F 1 UNP P20292 MET 1 MODIFIED RESIDUE SEQADV 2Q7R MSE F 89 UNP P20292 MET 89 MODIFIED RESIDUE SEQADV 2Q7R MSE F 125 UNP P20292 MET 125 MODIFIED RESIDUE SEQADV 2Q7R ALA F 148 UNP P20292 LYS 148 ENGINEERED MUTATION SEQRES 1 A 161 MSE ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 A 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 A 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 A 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 A 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 A 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 A 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MSE TYR LEU SEQRES 8 A 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 A 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 A 161 ILE ILE LEU PHE LEU PHE LEU MSE SER VAL ALA GLY ILE SEQRES 11 A 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 A 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 A 161 LEU LEU LEU ILE PRO SEQRES 1 B 161 MSE ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 B 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 B 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 B 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 B 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 B 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 B 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MSE TYR LEU SEQRES 8 B 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 B 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 B 161 ILE ILE LEU PHE LEU PHE LEU MSE SER VAL ALA GLY ILE SEQRES 11 B 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 B 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 B 161 LEU LEU LEU ILE PRO SEQRES 1 C 161 MSE ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 C 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 C 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 C 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 C 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 C 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 C 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MSE TYR LEU SEQRES 8 C 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 C 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 C 161 ILE ILE LEU PHE LEU PHE LEU MSE SER VAL ALA GLY ILE SEQRES 11 C 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 C 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 C 161 LEU LEU LEU ILE PRO SEQRES 1 D 161 MSE ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 D 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 D 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 D 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 D 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 D 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 D 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MSE TYR LEU SEQRES 8 D 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 D 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 D 161 ILE ILE LEU PHE LEU PHE LEU MSE SER VAL ALA GLY ILE SEQRES 11 D 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 D 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 D 161 LEU LEU LEU ILE PRO SEQRES 1 E 161 MSE ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 E 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 E 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 E 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 E 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 E 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 E 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MSE TYR LEU SEQRES 8 E 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 E 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 E 161 ILE ILE LEU PHE LEU PHE LEU MSE SER VAL ALA GLY ILE SEQRES 11 E 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 E 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 E 161 LEU LEU LEU ILE PRO SEQRES 1 F 161 MSE ASP GLN GLU THR VAL GLY ASN VAL VAL LEU LEU ALA SEQRES 2 F 161 ILE VAL THR LEU ILE SER VAL VAL GLN ASN GLY PHE PHE SEQRES 3 F 161 ALA HIS LYS VAL GLU HIS GLU SER ARG THR GLN ASN GLY SEQRES 4 F 161 ARG SER PHE GLN ARG THR GLY THR LEU ALA PHE GLU ARG SEQRES 5 F 161 VAL TYR THR ALA ASN GLN ASN CYS VAL ASP ALA TYR PRO SEQRES 6 F 161 THR PHE LEU ALA VAL LEU TRP SER ALA GLY LEU LEU CYS SEQRES 7 F 161 SER GLN VAL PRO ALA ALA PHE ALA GLY LEU MSE TYR LEU SEQRES 8 F 161 PHE VAL ARG GLN LYS TYR PHE VAL GLY TYR LEU GLY GLU SEQRES 9 F 161 ARG THR GLN SER THR PRO GLY TYR ILE PHE GLY LYS ARG SEQRES 10 F 161 ILE ILE LEU PHE LEU PHE LEU MSE SER VAL ALA GLY ILE SEQRES 11 F 161 PHE ASN TYR TYR LEU ILE PHE PHE PHE GLY SER ASP PHE SEQRES 12 F 161 GLU ASN TYR ILE ALA THR ILE SER THR THR ILE SER PRO SEQRES 13 F 161 LEU LEU LEU ILE PRO MODRES 2Q7R MSE A 1 MET SELENOMETHIONINE MODRES 2Q7R MSE A 89 MET SELENOMETHIONINE MODRES 2Q7R MSE A 125 MET SELENOMETHIONINE MODRES 2Q7R MSE B 1 MET SELENOMETHIONINE MODRES 2Q7R MSE B 89 MET SELENOMETHIONINE MODRES 2Q7R MSE B 125 MET SELENOMETHIONINE MODRES 2Q7R MSE C 1 MET SELENOMETHIONINE MODRES 2Q7R MSE C 89 MET SELENOMETHIONINE MODRES 2Q7R MSE C 125 MET SELENOMETHIONINE MODRES 2Q7R MSE D 1 MET SELENOMETHIONINE MODRES 2Q7R MSE D 89 MET SELENOMETHIONINE MODRES 2Q7R MSE D 125 MET SELENOMETHIONINE MODRES 2Q7R MSE E 1 MET SELENOMETHIONINE MODRES 2Q7R MSE E 89 MET SELENOMETHIONINE MODRES 2Q7R MSE E 125 MET SELENOMETHIONINE MODRES 2Q7R MSE F 1 MET SELENOMETHIONINE MODRES 2Q7R MSE F 89 MET SELENOMETHIONINE MODRES 2Q7R MSE F 125 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 89 8 HET MSE A 125 8 HET MSE B 1 8 HET MSE B 89 8 HET MSE B 125 8 HET MSE C 1 8 HET MSE C 89 8 HET MSE C 125 8 HET MSE D 1 8 HET MSE D 89 8 HET MSE D 125 8 HET MSE E 1 8 HET MSE E 89 8 HET MSE E 125 8 HET MSE F 1 8 HET MSE F 89 8 HET MSE F 125 8 HET 3CS A 503 43 HET 3CS B 502 43 HET 3CS C 501 43 HET 3CS D 505 43 HET 3CS E 506 43 HET 3CS F 504 43 HETNAM MSE SELENOMETHIONINE HETNAM 3CS 3-[3-(3,3-DIMETHYLBUTANOYL)-1-(4-IODOBENZYL)-5- HETNAM 2 3CS (QUINOLIN-2-YLMETHOXY)-1H-INDOL-2-YL]-2,2- HETNAM 3 3CS DIMETHYLPROPANOIC ACID FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 7 3CS 6(C36 H37 I N2 O4) HELIX 1 1 ASP A 2 ASN A 8 1 7 HELIX 2 2 VAL A 9 GLN A 37 1 29 HELIX 3 3 THR A 47 CYS A 78 1 32 HELIX 4 4 SER A 79 TYR A 101 1 23 HELIX 5 5 GLY A 115 PHE A 139 1 25 HELIX 6 6 ASP B 2 ASN B 8 1 7 HELIX 7 7 VAL B 9 THR B 36 1 28 HELIX 8 8 THR B 47 CYS B 78 1 32 HELIX 9 9 GLN B 80 TYR B 101 1 22 HELIX 10 10 LYS B 116 PHE B 139 1 24 HELIX 11 11 ASP C 2 ASN C 8 1 7 HELIX 12 12 VAL C 9 GLN C 37 1 29 HELIX 13 13 THR C 47 CYS C 78 1 32 HELIX 14 14 VAL C 81 ALA C 83 1 3 HELIX 15 15 ALA C 84 TYR C 101 1 18 HELIX 16 16 LYS C 116 PHE C 139 1 24 HELIX 17 17 ASP D 2 ASN D 8 1 7 HELIX 18 18 VAL D 9 GLN D 37 1 29 HELIX 19 19 THR D 47 CYS D 78 1 32 HELIX 20 20 SER D 79 TYR D 101 1 23 HELIX 21 21 LYS D 116 PHE D 139 1 24 HELIX 22 22 ASP E 2 ASN E 8 1 7 HELIX 23 23 VAL E 9 ASN E 38 1 30 HELIX 24 24 THR E 47 CYS E 78 1 32 HELIX 25 25 GLN E 80 GLY E 103 1 24 HELIX 26 26 GLY E 115 PHE E 139 1 25 HELIX 27 27 ASP F 2 ASN F 8 1 7 HELIX 28 28 VAL F 9 GLN F 37 1 29 HELIX 29 29 THR F 47 CYS F 78 1 32 HELIX 30 30 GLN F 80 TYR F 101 1 22 HELIX 31 31 LYS F 116 PHE F 138 1 23 HELIX 32 32 PHE F 139 SER F 141 5 3 LINK C MSE A 1 N ASP A 2 1555 1555 1.33 LINK C LEU A 88 N MSE A 89 1555 1555 1.33 LINK C MSE A 89 N TYR A 90 1555 1555 1.33 LINK C LEU A 124 N MSE A 125 1555 1555 1.33 LINK C MSE A 125 N SER A 126 1555 1555 1.33 LINK C MSE B 1 N ASP B 2 1555 1555 1.33 LINK C LEU B 88 N MSE B 89 1555 1555 1.33 LINK C MSE B 89 N TYR B 90 1555 1555 1.33 LINK C LEU B 124 N MSE B 125 1555 1555 1.32 LINK C MSE B 125 N SER B 126 1555 1555 1.33 LINK C MSE C 1 N ASP C 2 1555 1555 1.34 LINK C LEU C 88 N MSE C 89 1555 1555 1.33 LINK C MSE C 89 N TYR C 90 1555 1555 1.33 LINK C LEU C 124 N MSE C 125 1555 1555 1.32 LINK C MSE C 125 N SER C 126 1555 1555 1.33 LINK C MSE D 1 N ASP D 2 1555 1555 1.33 LINK C LEU D 88 N MSE D 89 1555 1555 1.33 LINK C MSE D 89 N TYR D 90 1555 1555 1.33 LINK C LEU D 124 N MSE D 125 1555 1555 1.32 LINK C MSE D 125 N SER D 126 1555 1555 1.33 LINK C MSE E 1 N ASP E 2 1555 1555 1.33 LINK C LEU E 88 N MSE E 89 1555 1555 1.33 LINK C MSE E 89 N TYR E 90 1555 1555 1.33 LINK C LEU E 124 N MSE E 125 1555 1555 1.33 LINK C MSE E 125 N SER E 126 1555 1555 1.33 LINK C MSE F 1 N ASP F 2 1555 1555 1.33 LINK C LEU F 88 N MSE F 89 1555 1555 1.33 LINK C MSE F 89 N TYR F 90 1555 1555 1.33 LINK C LEU F 124 N MSE F 125 1555 1555 1.33 LINK C MSE F 125 N SER F 126 1555 1555 1.33 SITE 1 AC1 12 VAL A 21 ASN A 23 GLY A 24 PHE A 25 SITE 2 AC1 12 ALA A 27 ASP C 62 THR C 66 ILE C 113 SITE 3 AC1 12 PHE C 114 ILE C 119 LEU C 120 PHE C 123 SITE 1 AC2 12 ASP B 62 ALA B 63 PHE B 114 LYS B 116 SITE 2 AC2 12 ILE B 119 LEU B 120 PHE B 123 VAL C 21 SITE 3 AC2 12 ASN C 23 GLY C 24 PHE C 25 ALA C 27 SITE 1 AC3 11 ASP A 62 LYS A 116 ILE A 119 LEU A 120 SITE 2 AC3 11 PHE A 123 VAL B 21 ASN B 23 GLY B 24 SITE 3 AC3 11 PHE B 25 ALA B 27 HIS B 28 SITE 1 AC4 12 VAL D 21 ASN D 23 GLY D 24 PHE D 25 SITE 2 AC4 12 ALA D 27 ASP F 62 ALA F 63 PHE F 114 SITE 3 AC4 12 LYS F 116 ILE F 119 LEU F 120 PHE F 123 SITE 1 AC5 13 ASP D 62 ALA D 63 THR D 66 ILE D 113 SITE 2 AC5 13 LYS D 116 ILE D 119 LEU D 120 PHE D 123 SITE 3 AC5 13 VAL E 21 ASN E 23 GLY E 24 PHE E 25 SITE 4 AC5 13 ALA E 27 SITE 1 AC6 12 ASP E 62 TYR E 112 LYS E 116 ILE E 119 SITE 2 AC6 12 LEU E 120 PHE E 123 VAL F 21 ASN F 23 SITE 3 AC6 12 GLY F 24 PHE F 25 ALA F 27 HIS F 28 CRYST1 180.660 180.660 139.990 90.00 90.00 90.00 P 4 21 2 48 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005535 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005535 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007143 0.00000 HETATM 1 N MSE A 1 49.603 61.911 10.851 1.00129.01 N HETATM 2 CA MSE A 1 49.334 63.339 10.985 1.00129.01 C HETATM 3 C MSE A 1 48.585 63.855 9.766 1.00129.01 C HETATM 4 O MSE A 1 49.104 63.793 8.654 1.00129.01 O HETATM 5 CB MSE A 1 50.654 64.089 11.061 1.00129.01 C HETATM 6 CG MSE A 1 51.348 64.118 12.404 1.00129.01 C HETATM 7 SE MSE A 1 50.975 65.690 13.486 1.00129.01 SE HETATM 8 CE MSE A 1 49.153 65.307 13.934 1.00129.01 C